NASDAQ · MOLN
Molecular Partners AG
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for MOLN has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Dec 2026 | $-0.46 | $-0.46 | $-0.46 | 1 |
| Mar 2027 | $-0.47 | $-0.47 | $-0.47 | 1 |
| Jun 2027 | $-0.42 | $-0.42 | $-0.42 | 1 |
| Sep 2027 | $-0.38 | $-0.38 | $-0.38 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Fintel · RTTNews · Zacks · Quiver Quantitative- Fintel · Oct 29, 7:42 AM EDTMolecular Partners AG Announces Strategic Shift to Radiopharmaceuticals and Intends to Reduce Workforce by No More Than 55 PositionsMolecular Partners AG announced a strategic shift to deepen its focus on radiopharmaceuticals and streamline its capabilities and resources, resulting in a pipeline prioritization and operating cost reductions. As part of this restructuring, the Company informed the Amt für
- RTTNews · Aug 25, 6:18 AM EDTMolecular Partners Reports H1 2026 Results, Advances DLL3 Radiotherapy MP0712(RTTNews) – Molecular Partners AG (MOLN) has reported first-half 2026 financial results and outlined progress across its DARPin-based pipeline, including the advancement of its DLL3-targeting radiotherapy candidate MP0712.
- RTTNews · Jul 16, 3:38 AM EDTMolecular Partners Advances Phase 2 Study Of MP0317 In Cholangiocarcinoma; Stock Up(RTTNews) – Molecular Partners AG (MOLN) has announced clinical progress in its Phase 2 proof-of-concept study evaluating MP0317 in combination with chemoimmunotherapy for patients with advanced biliary tract carcinoma (TACTIC), also known as cholangiocarcinoma.
- RTTNews · Jul 16, 3:38 AM EDTMolecular Partners Advanced Phase 2 Study Of MP0317 In Cholangiocarcinoma; Stock Up(RTTNews) – Molecular Partners AG (MOLN) has announced clinical progress in its Phase 2 proof-of-concept study evaluating MP0317 in combination with chemoimmunotherapy for patients with advanced biliary tract carcinoma (TACTIC), also known as cholangiocarcinoma.
- RTTNews · Jul 6, 5:53 AM EDTMolecular Partners To Advance MP0726 For First Human Imaging In H2,2026; Provides MP0712 Update(RTTNews) – Molecular Partners AG (MOLN), a clinical-stage biotech company, provided an update on its pipeline of targeted alpha-Radio-Designed Ankyrin Repeat Protein (DARPin) therapeutics.
- Zacks · Mar 4, 8:29 AM ESTWill Petrobras Pull Off Q4 Earnings Beat on Strong Production?PBR gears up for fourth-quarter results as pre-salt output hits 3,109 MBOE/d, but refining outages and weaker fuel production may weigh on margins.
- Fintel · Jan 27, 7:04 AM ESTHC Wainwright & Co. Initiates Coverage of Molecular Partners AG – Depositary Receipt (MOLN) with Buy RecommendationFintel reports that on January 27, 2026, HC Wainwright & Co. initiated coverage of Molecular Partners AG – Depositary Receipt (NasdaqGS:MOLN) with a Buy recommendation. Analyst Price Forecast Suggests 221.87% Upside
- Fintel · Dec 8, 7:03 PM ESTJP Morgan Maintains Molecular Partners AG – Depositary Receipt (MOLN) Neutral RecommendationFintel reports that on December 8, 2025, JP Morgan maintained coverage of Molecular Partners AG – Depositary Receipt (NasdaqGS:MOLN) with a Neutral recommendation. Analyst Price Forecast Suggests 208.42% Upside
- Fintel · Nov 9, 1:12 AM ESTMolecular Partners AG – Depositary Receipt (MOLN) Price Target Increased by 11.97% to 15.45The average one-year price target for Molecular Partners AG – Depositary Receipt (NasdaqGS:MOLN) has been revised to $15.45 / share. This is an increase of 11.97% from the prior estimate of $13.80 dated October 29, 2025. The price target is an average of many
- Quiver Quantitative · Jun 22, 4:10 PM EDTMolecular Partners AG and Orano Med Advance Development of MP0726 Radio-DARPin Candidate for Ovarian Cancer TreatmentMolecular Partners' MP0726, a Radio-DARPin targeting mesothelin, shows promising preclinical results for ovarian cancer treatment.
- Quiver Quantitative · Jun 11, 4:13 PM EDTMolecular Partners Reports Positive Phase 1/2a Data for MP0533 in Relapsed/Refractory AML at EHA CongressThree of eight relapsed/refractory AML patients responded positively to MP0533 in cohort 8, with ongoing safety evaluations.
- Quiver Quantitative · Apr 25, 4:12 PM EDTMolecular Partners Reports Positive IND-Enabling Data for MP0712 and Advances Radio-DARPin Programs with Orano Med at AACR 2025Molecular Partners announced positive IND-enabling data for MP0712 and preclinical findings for novel targeted Radio-DARPins at AACR 2025.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Molecular Partners AG from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.